CAR-T Cells: A Systematic Review and Mixed Methods Analysis of the Clinical Trial Landscape-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CAR-T Cells: A Systematic Review and Mixed Methods Analysis of the Clinical Trial Landscape

Published:2018-02 Issue:2 Volume:26 Page:342-353
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Pettitt David,Arshad Zeeshaan,Smith James,Stanic Tijana,Holländer Georg,Brindley David

Funder

SENS Research Foundation

MRC

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference39 articles.

1. A regional approach for CAR T-cell therapy for mesothelioma: from mouse models to clinical trial;Mayor;Immunotherapy,2016

2. Biology and clinical application of CAR T cells for B cell malignancies;Davila;Int. J. Hematol.,2016

3. Novel agents for diffuse large B-cell lymphoma;Sinha;Expert Opin. Investig. Drugs,2011

4. Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors;Kochenderfer;Nat. Rev. Clin. Oncol.,2013

5. Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity;Gross;Proc. Natl. Acad. Sci. USA,1989

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory landscape and challenges in CAR-T cell therapy development in the US, EU, Japan, and India;European Journal of Pharmaceutics and Biopharmaceutics;2024-08

2. From stem cells to regulatory T cells: A tale of plasticity;Cell Stem Cell;2024-06

3. The Implementation of Chimeric Antigen Receptor (CAR) T-cell Therapy in Pediatric Patients: Where Did We Come From, Where Are We Now, and Where are We Going?;Clinical Hematology International;2024-03-13

4. The Art of Bioimmunogenomics (BIGs) 5.0 in CAR-T Cell Therapy for Lymphoma Management;Advanced Pharmaceutical Bulletin;2024-03-10

5. A trispecific antibody induces potent tumor-directed T-cell activation and antitumor activity by CD3/CD28 co-engagement;Immunotherapy;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3